2025-06-12-花旗集团-为了您的健康_每周健康科技与分销数据包_41页_495kb

Citi Research's Health Tech and Distribution Weekly report dated June 13, 2025, provides an analysis of the health technology and distribution sector. Key highlights include:

• Stock performance for the week showed health tech generally negative, while distributors rose, with companies like GDRX and IQV outperforming. Year-to-date and last twelve months data also cover trends.
• Subsector breakdowns reveal shifts, with virtual health and tech-enabled payers showing mixed results, driven by factors like FDA guidance and GLP-1 drugs.
• Financial data for companies like HIMS, TDOC, and GDRX indicate recent sales, transactions, and average transaction values. HIMS sales increased year-over-year, but transaction numbers declined weekly; TDOC experienced a weekly dip in sales, while GDRX maintained steady performance.
• Website visits, app downloads, and daily active users tracking show growth for some companies (e.g., HIMS's DAU surged), but variability across metrics suggests evolving user engagement.
• The GLP-1 tracker reported a 6.5% weekly decline in sales, impacting prescriptions, despite long-term usage growth.
• Provider visit volumes increased year-over-year but dropped week-on-week, indicating short-term volatility but sustained interest in services.
• The report also notes potential conflicts of interest and legal disclosures typical of financial research firms.

This summary reflects the data provided and underscores the dynamic nature of the health tech and distribution market.